Technical Analysis for ALUR - Allurion Technologies, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.34 | -14.25% | -0.06 |
ALUR closed down 14.25 percent on Friday, November 15, 2024, on 5.91 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Down 1 ATR | 1 day ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
| Down 10% | 1 day ago |
| 2x Volume Pace | 1 day ago |
| 1.5x Volume Pace | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/13/2024
Allurion is dedicated to ending obesity. The Allurion Program is a weight loss platform that combines the Allurion Gastric Balloon, the world’s first and only swallowable, procedure-less gastric balloon for weight loss, the Allurion Virtual Care Suite including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform, and the Allurion Connected Scale and Health Tracker devices. The Allurion Virtual Care Suite is also available to providers separately from the Allurion Program to help customize, monitor and manage weight loss therapy for patients regardless of their treatment plan: gastric balloon, surgical, medical or nutritional.
Sector: Healthcare
Industry: Medical Devices
Keywords: Obesity Digestive System Surgery Weight Loss Bariatrics
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Obesity Digestive System Surgery Weight Loss Bariatrics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.24 |
| 52 Week Low | 0.31 |
| Average Volume | 178,496 |
| 200-Day Moving Average | 1.47 |
| 50-Day Moving Average | 0.67 |
| 20-Day Moving Average | 0.68 |
| 10-Day Moving Average | 0.63 |
| Average True Range | 0.09 |
| RSI (14) | 21.26 |
| ADX | 40.14 |
| +DI | 11.09 |
| -DI | 34.21 |
| Chandelier Exit (Long, 3 ATRs) | 0.54 |
| Chandelier Exit (Short, 3 ATRs) | 0.57 |
| Upper Bollinger Bands | 0.91 |
| Lower Bollinger Band | 0.45 |
| Percent B (%b) | -0.24 |
| BandWidth | 66.99 |
| MACD Line | -0.05 |
| MACD Signal Line | -0.01 |
| MACD Histogram | -0.0416 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.48 | ||||
| Resistance 3 (R3) | 0.49 | 0.44 | 0.46 | ||
| Resistance 2 (R2) | 0.44 | 0.41 | 0.44 | 0.45 | |
| Resistance 1 (R1) | 0.39 | 0.39 | 0.37 | 0.39 | 0.44 |
| Pivot Point | 0.35 | 0.35 | 0.34 | 0.35 | 0.35 |
| Support 1 (S1) | 0.30 | 0.32 | 0.28 | 0.30 | 0.24 |
| Support 2 (S2) | 0.26 | 0.29 | 0.26 | 0.24 | |
| Support 3 (S3) | 0.21 | 0.26 | 0.23 | ||
| Support 4 (S4) | 0.21 |
